{"DataElement":{"publicId":"5254403","version":"1","preferredName":"Lymph Node Radiation Therapy Total Fraction Known Yes No Indicator","preferredDefinition":"Text term to signify whether the total number of radiation fractions administered to targeted regional lymph nodes is known.","longName":"LN_RT_FRCT_KWN_IND","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"5254314","version":"1","preferredName":"Lymph Node Radiation Therapy Total Fraction Known","preferredDefinition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection._information related to radiation therapy administered to a patient._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._Dividing the total dose of radiation therapy into several smaller, equal doses delivered over a period of several days._Recognized, familiar, or within the scope of knowledge.","longName":"3762191v1.0:5255761v1.0","context":"BOLD","contextVersion":"1","ObjectClass":{"publicId":"3762191","version":"1","preferredName":"Lymph Node Radiation Therapy","preferredDefinition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.:Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","longName":"C12745:C15313","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymph Node","conceptCode":"C12745","definition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCC202BA-4C25-D2FF-E040-BB89AD433A32","latestVersionIndicator":"Yes","beginDate":"2013-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5255761","version":"1","preferredName":"Total Fractionation Known","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.:Dividing the total dose of radiation therapy into several smaller, equal doses delivered over a period of several days.:Recognized, familiar, or within the scope of knowledge.","longName":"C25304:C15654:C80137","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fractionated Radiotherapy","conceptCode":"C15654","definition":"Radiation therapy in which the total dose delivered is divided into several smaller, equal doses delivered over a period of several days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Known","conceptCode":"C80137","definition":"Recognized, familiar, or within the scope of knowledge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3293466C-97AF-F333-E050-BB89AD437E58","latestVersionIndicator":"Yes","beginDate":"2016-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-11","modifiedBy":"ONEDATA","dateModified":"2016-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"322CCDA2-013A-ECA7-E050-BB89AD436749","latestVersionIndicator":"Yes","beginDate":"2016-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"ISO 11179 compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461591","version":"1","longName":"Radiation Elements","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Is Total # of fractions known?","type":"Preferred Question Text","description":"Is Total # of fractions known?","url":null,"context":"BOLD"}],"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"322FD247-86E5-C179-E050-BB89AD437652","latestVersionIndicator":"Yes","beginDate":"2016-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-06","modifiedBy":"REEVESD","dateModified":"2016-09-06","changeDescription":"Curated for BOLD Radiation CRF to allow numeric fields of dose and fraction # to include the option to collect an unknown response.5.6.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}